期刊文献+
共找到1,333篇文章
< 1 2 67 >
每页显示 20 50 100
Promoter hypermethylation of tissue specific tumor supressor genes and point mutation in K-ras, c-myc proto-oncogenes in urinary (transitional cell) bladder carcinoma
1
作者 Ozturk Ozdemir Esin Yildiz +4 位作者 Semih Ayan Eylem Gul Gokhan Gokce Fazilet Yildiz Binnur Koksal 《Health》 2010年第8期850-856,共7页
In a total of 83 UN specimens were investigated for proto-oncogene mutations, tumor supressor genes promoter methylation status and c-myc and Ki-67 expression. Point mutations in c-myc were detected in cases with high... In a total of 83 UN specimens were investigated for proto-oncogene mutations, tumor supressor genes promoter methylation status and c-myc and Ki-67 expression. Point mutations in c-myc were detected in cases with high grade and proliferation index. Mutated K-ras proto-onco- gene profiles were detected in 17 (21%) tumoral spiecemens that examined. Tumor specimens were also showed hypermethylated promoter domain for the SFRP2, MGMT tumor supressor genes. These findings showed the combine effect of mutated c-myc and K-ras oncogene and epigenetic inactivation of tissue specific tumor supressor genes (TS) play a crucial role in tumor progression and recurrence in UN carcinogenesis. 展开更多
关键词 C-MYC K-RAS Ki-67 urinary bladder Urothelial neoplasms Promoter Hypermethylation Tumor Supressor Genes
下载PDF
经尿道钬激光整块切除术治疗高危非肌层浸润性膀胱癌47例疗效及术后并发症与复发风险的观察
2
作者 马光 李红阳 +4 位作者 宋殿宾 马红亮 李俊鹏 辛立升 王志勇 《安徽医药》 CAS 2024年第4期804-808,共5页
目的 探讨经尿道钬激光整块切除术治疗高危非肌层浸润性膀胱癌(NMIBC)的效果。方法 选取2019年1月至2021年5月承德医学院附属医院94例高危NMIBC病人进行前瞻性研究,按随机数字表法分组,各47例。对照组行经尿道膀胱肿瘤等离子电切术,观... 目的 探讨经尿道钬激光整块切除术治疗高危非肌层浸润性膀胱癌(NMIBC)的效果。方法 选取2019年1月至2021年5月承德医学院附属医院94例高危NMIBC病人进行前瞻性研究,按随机数字表法分组,各47例。对照组行经尿道膀胱肿瘤等离子电切术,观察组行经尿道钬激光整块切除术。比较两组手术相关指标、临床疗效、手术前后外周血循环肿瘤细胞(CTCs)计数、肿瘤标志物[癌胚抗原(CEA)、膀胱肿瘤抗原(BTA)、糖链抗原19-9(CA19-9)]、并发症及预后情况。结果 观察组术中出血量、膀胱冲洗、尿管留置及术后住院时间分别为(25.10±4.12)mL、(18.65±6.74)min、(19.57±3.48)h、(8.01±1.69)d,均优于对照组的(43.25±6.78)mL、(24.78±8.12)min、(35.24±5.12)h、(15.32±2.89)d(P<0.05);观察组总有效率87.23%高于对照组68.09%(P<0.05);术后72 h观察组外周血CTCs计数为5.47±2.00,低于对照组的8.96±3.12(P<0.05);术后3、6、12个月观察组血清BTA、CEA、CA19-9水平低于对照组(P<0.05);观察组并发症发生率6.38%(3例)低于对照组23.40%(11例)(P<0.05);术后随访1年,观察组病人1年无复发生存率97.83%(45/46)与对照组90.91%(40/44)比较,差异无统计学意义(P>0.05)。结论 经尿道钬激光整块切除术可提高高危NMIBC病人临床疗效,减少并发症,加速术后康复进程,并可减少外周血循环肿瘤细胞,降低肿瘤标志物水平。 展开更多
关键词 膀胱肿瘤 膀胱切除术 钬激光 非肌层浸润性膀胱癌 并发症 复发
下载PDF
SCAMP2和SCAMP3在膀胱癌中的表达及意义
3
作者 曲婷婷 赵树超 +2 位作者 闫伟华 张翔雁 贾长新 《青岛大学学报(医学版)》 CAS 2024年第2期222-226,共5页
目的探讨分泌载体相关膜蛋白2和3(SCAMP2和SCAMP3)在膀胱癌(BC)中的表达及其意义。方法应用免疫组织化学法检测181例BC及相应癌旁组织中SCAMP2和SCAMP3的表达水平。结果与相应癌旁组织相比较,SCAMP2和SCAMP3在BC组织中的表达水平显著升... 目的探讨分泌载体相关膜蛋白2和3(SCAMP2和SCAMP3)在膀胱癌(BC)中的表达及其意义。方法应用免疫组织化学法检测181例BC及相应癌旁组织中SCAMP2和SCAMP3的表达水平。结果与相应癌旁组织相比较,SCAMP2和SCAMP3在BC组织中的表达水平显著升高(χ^(2)=41.242、110.576,P<0.001)。SCAMP2高表达与饮酒史和癌症家族史有关(χ^(2)=4.784、3.904,P<0.05)。SCAMP3高表达与浸润性BC和癌症家族史有关(χ^(2)=6.893、7.411,P<0.05)。预后分析显示,SCAMP2和SCAMP3表达与BC病人预后没有相关性。结论SCAMP2和SCAMP3在BC组织中的高表达可能与BC的发生和进展密切相关,可能可以作为BC治疗的潜在靶点。 展开更多
关键词 膀胱肿瘤 载体蛋白质类 膜蛋白质类 疾病特征 预后 免疫组织化学
下载PDF
前列腺癌多参数MRI诊断及误诊原因分析
4
作者 韩磊 桑节峰 +2 位作者 孟钢 张虎 李大鹏 《临床误诊误治》 CAS 2024年第3期21-25,共5页
目的 探讨前列腺癌临床特点、多参数MRI表现,总结其误诊原因及防范措施。方法 对2020年4月—2022年2月收治的多参数MRI检查后误诊为膀胱癌、前列腺增生的前列腺癌10例的临床资料进行回顾性分析。结果 10例年龄54~73岁。6例因尿急、尿频... 目的 探讨前列腺癌临床特点、多参数MRI表现,总结其误诊原因及防范措施。方法 对2020年4月—2022年2月收治的多参数MRI检查后误诊为膀胱癌、前列腺增生的前列腺癌10例的临床资料进行回顾性分析。结果 10例年龄54~73岁。6例因尿急、尿频、尿潴留、排尿困难就诊,直肠指诊示前列腺肥大,查血清前列腺特异性抗原升高,多参数MRI及前列腺穿刺活组织病理检查未发现前列腺肿瘤证据,误诊为前列腺增生,后经术后病理检查确诊T1期前列腺癌。4例以尿痛、血尿、排尿困难就诊,经多参数MRI检查误诊为膀胱癌,查血清前列腺特异性抗原升高,直肠指诊发现前列腺肥大,再次行多参数MRI和前列腺组织穿刺活组织病理检查证实为前列腺癌累及膀胱。误诊时间4~10 d。误诊为前列腺增生6例接受根治性手术,误诊为膀胱癌4例予内分泌和放射治疗,随访至今病情控制尚可。结论 临床接诊以尿急、尿频、尿潴留、排尿困难等症状就诊的中老年男性患者时应考虑到前列腺癌可能。加强对前列腺癌影像学特征认识,行多参数MRI检查时重点观察前列腺结构、包膜完整与否、膀胱壁连续性等重要特征,必要时可行前列腺穿刺活组织病理检查,以提高该病术前诊断正确率。 展开更多
关键词 前列腺肿瘤 误诊 膀胱肿瘤 前列腺增生 多参数MRI 直肠指诊 前列腺特异性抗原 病理检查
下载PDF
基于DWI影像特征及定量参数对VI-RADS 2分膀胱癌肌层浸润性的评估
5
作者 何康文 孟晓岩 +4 位作者 冯翠 王艳春 胡道予 牛永华 李震 《放射学实践》 CSCD 北大核心 2024年第6期761-766,共6页
目的:探讨基于DWI影像特征及定量分析参数对DWI VI-RADS 2分带蒂膀胱癌的肌层浸润性评估价值。方法:回顾性搜集2020年9月-2021年12月经手术病理证实的54例膀胱癌患者临床及MR影像资料,所有患者DWI VI-RADS均为2分,据病理结果分为非肌层... 目的:探讨基于DWI影像特征及定量分析参数对DWI VI-RADS 2分带蒂膀胱癌的肌层浸润性评估价值。方法:回顾性搜集2020年9月-2021年12月经手术病理证实的54例膀胱癌患者临床及MR影像资料,所有患者DWI VI-RADS均为2分,据病理结果分为非肌层浸润性膀胱癌(NMIBC,31例)和肌层浸润性膀胱癌(MIBC,23例)。采用独立样本t检验、Mann-Whitney U检验、卡方检验比较两组之间临床特征、影像定性及定量参数的差异,单因素分析获得具有统计学意义的参数,采用受试者工作特征(ROC)曲线评估各定量参数对DWI VI-RADS 2分膀胱癌肌层浸润评估的诊断效能,并计算定量参数的最佳截断值。结果:单因素分析显示MIBC组与NMIBC组在肿瘤病理分级、肿瘤形态及蒂形态方面差异具有统计学意义(P<0.01)。带蒂测量的MIBC组ADC值低于NIMIBC组,差异具有统计学意义(P<0.05),不带蒂测量的MIBC组ADC值低于NMIBC组,但差异无统计学意义(P=0.08)。带蒂ADC、蒂最宽、宽度比、肿瘤形态、蒂形态、蒂居中及基底部光滑预测DWI VI-RADS 2分膀胱癌肌层浸润的AUC分别为0.67、0.69、0.83、0.74、0.84、0.78、0.63。结论:带蒂ADC值、肿瘤形态及蒂形态对预测DWI VI-RADS 2分膀胱癌肌层浸润具有一定的诊断帮助,以肿瘤蒂形态及宽度比较为显著。 展开更多
关键词 膀胱肿瘤 磁共振成像 病理学
下载PDF
16例膀胱肉瘤样癌临床病理特征及疗效分析
6
作者 庞月文 闫永吉 +9 位作者 贾通宇 李培哲 贺爽 韩思宇 钟然 赵世雨 时京 段珺耀 马鑫 巩会杰 《微创泌尿外科杂志》 2024年第1期41-44,共4页
目的:探讨膀胱肉瘤样癌患者的临床病理特征、诊疗及预后。方法:回顾性分析2006年12月至2017年12月我院收治的16例膀胱肉瘤样癌患者的临床病理及随访资料。结果:本组16例患者中男性11例,女性5例;平均年龄58岁。以肉眼血尿为主要临床表现... 目的:探讨膀胱肉瘤样癌患者的临床病理特征、诊疗及预后。方法:回顾性分析2006年12月至2017年12月我院收治的16例膀胱肉瘤样癌患者的临床病理及随访资料。结果:本组16例患者中男性11例,女性5例;平均年龄58岁。以肉眼血尿为主要临床表现。肿瘤最大直径范围为0.8~13cm。16例患者均行手术治疗,3例行经尿道膀胱肿瘤切除术,5例行膀胱部分切除术,8例行根治性膀胱切除术+尿流改道术。术后病理分期:T1N0M0期4例,T1N0M1期1例,T2aN0M0期3例,T2bN0M0期2例,T3bN0M1期1例,T4aN0M0期2例,T4aN0M1期1例,T4aN2M0期2例。13例获得随访,3例失访,随访时间4~149个月,中位随访时间32个月。6例患者死亡,中位生存时间为6.5个月;7例患者术后存活,中位生存时间为95个月。结论:膀胱肉瘤样癌是一种罕见恶性肿瘤,预后较差,尚无最佳治疗方案,早期诊断、早期治疗是患者获得较好预后的重要条件。 展开更多
关键词 膀胱肿瘤 肉瘤样癌 诊断 治疗 预后
下载PDF
膀胱原位癌误诊分析并文献复习
7
作者 敖金文 黄欣 《临床误诊误治》 CAS 2024年第8期20-23,共4页
目的探讨膀胱原位癌的误诊原因及预防措施。方法回顾性分析2019年10月—2022年10月收治曾误诊的膀胱原位癌4例的临床资料。结果本组2例表现为尿频、尿急6月余,加剧1周,伴少量血尿;1例表现为排尿困难2月余;1例表现为排尿困难3年余,行前... 目的探讨膀胱原位癌的误诊原因及预防措施。方法回顾性分析2019年10月—2022年10月收治曾误诊的膀胱原位癌4例的临床资料。结果本组2例表现为尿频、尿急6月余,加剧1周,伴少量血尿;1例表现为排尿困难2月余;1例表现为排尿困难3年余,行前列腺电切术后出现尿路刺激症状10月余。初期诊断为慢性膀胱炎2例,尿道感染和前列腺炎各1例。误诊时间(10.34±2.26)周。按误诊疾病治疗后皆症状反复,后结合疾病特点和尿脱落细胞学、膀胱镜及病理检查等最终确诊为膀胱原位癌。3例行膀胱内注射卡介苗结合膀胱肿瘤电切术治疗症状改善,随访1~3年无复发;1例拒绝治疗和随访。结论膀胱原位癌无典型临床表现,易与泌尿系统感染性疾病相混淆,临床医师需加强对该病认识,提高对其鉴别诊断能力,并及时完善相关医技检查,以减少或避免其误诊误治。 展开更多
关键词 膀胱肿瘤 原位癌 误诊 膀胱炎 尿道感染 前列腺炎 诊断 鉴别诊断
下载PDF
Diagnosing upper tract urothelial carcinoma: A review of the role of diagnostic ureteroscopy and novel developments over last two decades
8
作者 Paul Gravestock Daniel Cullum +1 位作者 Bhaskar Somani Rajan Veeratterapillay 《Asian Journal of Urology》 CSCD 2024年第2期242-252,共11页
Objective: The role of ureteroscopy in the diagnosis of upper tract urothelial carcinoma is yet to be fully determined. We aimed to provide an up to date evaluation of its role and the emerging technologies in the fie... Objective: The role of ureteroscopy in the diagnosis of upper tract urothelial carcinoma is yet to be fully determined. We aimed to provide an up to date evaluation of its role and the emerging technologies in the field.Methods: A literature search of the last two decades (from 24th May, 2001 to 24th May, 2021) was carried out identifying 147 papers for potential inclusion within this narrative review.Results: Diagnostic ureteroscopy is undeniably useful in its ability to visualise and biopsy indeterminate lesions, and to risk stratify malignant lesions that may be suitable for kidney sparing surgery. However, an increased risk of intravesical recurrence following nephroureterectomy when a prior diagnostic ureteroscopy has been performed, inadequate sampling at biopsy, complications from the procedure, and difficult ureteric access are all potential drawbacks. Furthermore, whilst generally an accurate diagnostic procedure, it risks missing carcinoma in-situ lesions. Despite this, evidence shows that routine use of ureteroscopy changes the management of patients in a large proportion of cases, preventing unnecessary surgery or facilitating kidney sparing surgery. The overall rate of complications is low, and improved biopsy techniques and the use of tissue biomarkers for improved staging and grading are encouraging. The risks of delays to definitive management and post-ureteroscopy intravesical recurrence do not seem to affect survival, and trials are in progress to determine whether intravesical therapy can mitigate the latter. Further promising techniques are being investigated to improve shortcomings, particularly in relation to improved diagnosis of carcinoma in situ and preoperative staging.Conclusion: Ureteroscopy has a role in the diagnosis of upper tract malignancy, though whether it should be used routinely is yet to be determined. 展开更多
关键词 URETEROSCOPY CARCINOMA Transitional cell Ureteralneoplasms urinary bladder neoplasms Carcinomainsitu BIOPSY
下载PDF
膀胱癌组织微RNA-212、微RNA-137、微RNA-200表达与临床病理特征的相关性及预测经尿道膀胱肿瘤切除术后复发的效能研究
9
作者 张家兴 张际青 +5 位作者 杨云波 唐伟 刘海超 刘桂迁 李卫旗 裴志圣 《安徽医药》 CAS 2024年第4期727-732,共6页
目的 探讨膀胱癌组织微RNA-212(miRNA-212)、微RNA-137(miRNA-137)、微RNA-200(miRNA-200)表达与临床病理特征的相关性及预测经尿道膀胱肿瘤切除(TURBT)术后复发的效能。方法 选取2017年6月至2021年6月河北燕达医院100例膀胱癌病人,比... 目的 探讨膀胱癌组织微RNA-212(miRNA-212)、微RNA-137(miRNA-137)、微RNA-200(miRNA-200)表达与临床病理特征的相关性及预测经尿道膀胱肿瘤切除(TURBT)术后复发的效能。方法 选取2017年6月至2021年6月河北燕达医院100例膀胱癌病人,比较癌组织和癌旁组织及不同病理特征病人miRNA-212、miRNA-137、miRNA-200表达,并根据术后复发情况分为复发组、未复发组。比较两组miRNA-212、miRNA-137、miRNA-200表达,采用受试者操作特征(ROC)曲线分析miRNA-212、miRNA-137、miRNA-200预测复发的价值,比较不同miRNA-212、miRNA-137、miRNA-200表达水平病人复发率。结果 癌组织miRNA-212为2.03±0.56低于癌旁组织4.52±1.18(P<0.05),癌组织miRNA-137、miRNA-200表达分别为2.69±0.45、24.56±7.39,高于癌旁组织的1.28±0.30、7.33±2.21(P<0.05);随着组织学分级、TNM分期递增,miRNA-212表达逐渐降低,miRNA-137、miRNA-200表达逐渐升高(P<0.05);肌层浸润性膀胱癌病人miRNA-212低于非肌层浸润性膀胱癌,miRNA-137、miRNA-200高于非肌层浸润性膀胱癌(P<0.05);复发组miRNA-212(1.73±0.39)低于未复发组(2.28±0.44)(P<0.05),复发组miRNA-137、miRNA-200分别为3.06±0.72、37.96±12.18,高于未复发组2.35±0.40、22.86±7.50(P<0.05);miRNA-212高水平病人复发率低于低水平病人,miRNA-137、miRNA-200高水平病人复发率高于低水平病人(P<0.05)。结论 膀胱癌组织miRNA-212、miRNA-137、miRNA-200表达与临床病理特征相关,联合检测对TURBT后复发具有良好的预测能力,可作为预测术后复发的一种方案。 展开更多
关键词 膀胱肿瘤 微RNA-212 微RNA-137 微RNA-200 肿瘤复发 局部
下载PDF
外周血miR-143、miR-33a表达与膀胱癌患者临床预后的相关性
10
作者 高永辉 彭贝贝 《医学临床研究》 CAS 2024年第1期25-28,共4页
【目的】探讨外周血miR-143、miR-33a表达与膀胱癌患者临床预后的相关性。【方法】选取2017年5月至2021年4月本院收治的60例膀胱癌患者(观察组),另选取同期体检的60例健康志愿者作为对照组。比较两组研究对象外周血miR-143、miR-33a表... 【目的】探讨外周血miR-143、miR-33a表达与膀胱癌患者临床预后的相关性。【方法】选取2017年5月至2021年4月本院收治的60例膀胱癌患者(观察组),另选取同期体检的60例健康志愿者作为对照组。比较两组研究对象外周血miR-143、miR-33a表达水平及不同病理特征患者外周血miR-143、miR-33a表达水平,评价外周血miR-143、miR-33a对膀胱癌的诊断价值,比较外周血miR-143、miR-33a不同表达膀胱癌患者生存曲线,分析外周血miR-143、miR-33a表达与膀胱癌患者死亡风险的关系。【结果】观察组患者外周血miR-143、miR-33a表达水平低于对照组患者,差异有统计学意义(P<0.05)。不同临床分期、组织分化程度、初发与复发及有无远处转移患者外周血miR-143、miR-33a表达水平比较,差异有统计学意义(P<0.05)。外周血miR-143、miR-33a联合诊断膀胱癌的曲线下面积为0.922,显著高于miR-143、miR-33a单一指标(P<0.05)。外周血miR-143、miR-33a低表达患者的术后3年生存率分别低于外周血miR-143、miR-33a高表达患者(P<0.05)。外周血miR-143、miR-33a低表达患者术后3年死亡风险是高表达患者的4.550倍、5.223倍(P<0.05)。【结论】膀胱癌患者miR-143、miR-33a表达下调,与病理特征密切相关,检测其表达水平有助于评估患者预后情况,具有较高临床价值。 展开更多
关键词 膀胱肿瘤/病理学 微RNAS 预后
下载PDF
Oral microbiota in the oral-genitourinary axis:identifying periodontitis as a potential risk of genitourinary cancers 被引量:3
11
作者 Shuai Yuan Cheng Fang +5 位作者 Wei-Dong Leng Lan Wu Bing-Hui Li Xing-Huan Wang Hailiang Hu Xian-Tao Zeng 《Military Medical Research》 SCIE CSCD 2021年第4期564-578,共15页
Periodontitis has been proposed as a novel risk factor of genitourinary cancers:although periodontitis and genitourinary cancers are two totally distinct types of disorders,epidemiological and clinical studies,have es... Periodontitis has been proposed as a novel risk factor of genitourinary cancers:although periodontitis and genitourinary cancers are two totally distinct types of disorders,epidemiological and clinical studies,have established associations between them.Dysbiosis of oral microbiota has already been established as a major factor contributing to periodontitis.Recent emerging epidemiological evidence and the detection of oral microbiota in genitourinary organs indicate the presence of an oral-genitourinary axis and oral microbiota may be involved in the pathogenesis of genitourinary cancers.Therefore,oral microbiota provides the bridge between periodontitis and genitourinary cancers.We have carried out this narrative review which summarizes epidemiological studies exploring the association between periodontitis and genitourinary cancers.We have also highlighted the current evidence demonstrating the capacity of oral microbiota to regulate almost all hallmarks of cancer,and proposed the potential mechanisms of oral microbiota in the development of genitourinary cancers. 展开更多
关键词 Oral microbiota Oral-genitourinary axis PERIODONTITIS Urogenital neoplasms Prostatic neoplasms Kidney neoplasms urinary bladder neoplasms
下载PDF
Robot-assisted laparoscopic radical cystectomy with complete intracorporeal urinary diversion 被引量:3
12
作者 Jason M.Sandberg Ashok K.Hemal 《Asian Journal of Urology》 2016年第3期156-166,共11页
Robot-assisted radical cystectomy with intracorporeal urinary diversion(RARCICUD)has only recently been explored as a viable surgical option for patients with muscle-invasive bladder cancer seeking satisfactory oncolo... Robot-assisted radical cystectomy with intracorporeal urinary diversion(RARCICUD)has only recently been explored as a viable surgical option for patients with muscle-invasive bladder cancer seeking satisfactory oncologic control while benefiting from minimally invasive surgical techniques.Inspired by earlier open and laparoscopic work,initial descriptions of RARC-ICUD were published in 2003,and have since been followed by multiple larger case series which have suggested promising outcomes for our patients.However,the rate of adoption has remained relatively slow when compared to other robotassisted procedures such as the radical prostatectomy,likely owing to longer operative times,operative complexity,costs,and uncertainty regarding oncologic efficacy.The operative technique for RARC-ICUD has evolved over the past decade and several high-volume centers have shared tips to improve efficiency and make the operation possible for a growing number of urologists.Though there are still questions regarding economic costs,effectiveness,and generalizability of outcomes reported in published data,a growing dataset has brought us ever closer to the answers.Here,we present our current operative technique for RARC-ICUD and discuss the state of the literature so that the urologist may hold an informed discussion with his or her patients. 展开更多
关键词 CYSTECTOMY ROBOTICS urinary bladder neoplasms urinary diversion
下载PDF
Significance of age and comorbidity as prognostic indicators for patients with bladder cancer 被引量:1
13
作者 Moon Soo Ha In Ho Chang 《Asian Journal of Andrology》 SCIE CAS CSCD 2010年第5期766-774,共9页
The aim of this study was to determine the impact that age and comorbidity status have on both overall and bladder cancer-specific survival of bladder cancer patients. We obtained medical information pertaining to a p... The aim of this study was to determine the impact that age and comorbidity status have on both overall and bladder cancer-specific survival of bladder cancer patients. We obtained medical information pertaining to a population of 528 patients with newly diagnosed bladder cancer from Chung-Ang University Hospital cancer registry. The Adult Comorbidity Evaluation-27 (ACE-27) test, which has been previously validated in adult cancer patients, was used to assess comorbidity. We evaluated differences in the demographic and clinical characteristics of included patients, as well as differences in the treatments they received after categorizing them by age. The median age at the time of bladder cancer diagnosis of the entire cohort was 63 years, and the median follow-up time was 97 months. Of the 528 patients who were included in our study, 303 had at least one comorbid condition and 249 died during the follow-up period. When patients were stratified by age, we found that older patients had a higher proportion of severe comorbidities (P 〈 0.01) than younger patients, and that a lower proportion of them underwent radical cystec- tomy for invasive bladder cancer (IBC) (P 〈 0.01). By multivariate analysis, we found that older age was predictive of lower overall survival (OS) and bladder cancer-specific survival (BCSS) rates among patients with superficial bladder cancer (SBC) and of lower OS rates among patients with IBC. We also found that moderate-severe comorbidity status and treatment through a bladder-conserving approach were predictive of lower OS and cancer-specific survival rates among patients with IBC. The disparity between overall deaths and bladder cancer deaths was shown in SBC and increased along with age and higher comorbidity. Age and comorbidity were found to be independent predictive factors of OS and BCSS among bladder cancer patients, and explained the disparity that we observed between overall bladder cancer-specific mortality rates. 展开更多
关键词 age COMORBIDITY neoplasm prognostic indicator urinary bladder
下载PDF
Superselective embolisation of bilateral superior vesical arteries for management of intractable hematuria in context of metastatic bladder cancer 被引量:2
14
作者 Ahmed Saadi Abderrazak Bouzouita +8 位作者 Mohamed Hedi Rebai Mohamed Cherif Walid Kerkeni Haroun Ayed Amine Derouiche Hatem Rajhi Riadh Ben Slama Najla Mnif Mohamed Chebil 《Asian Journal of Urology》 2017年第2期131-134,共4页
Hematuria due to locally advanced or metastatic bladder cancer is a common condition and is often a management problem.Percutaneous embolisation is a mini-invasive option to handle this situation.We report a case of a... Hematuria due to locally advanced or metastatic bladder cancer is a common condition and is often a management problem.Percutaneous embolisation is a mini-invasive option to handle this situation.We report a case of a patient with a metastatic bladder cancer and who presented with an abundant hematuria and severe anemia.After failure of endoscopic resections and“flush”of radiotherapy haemostatic and refusal of cystectomy by the patient,he was treated by superselective embolisation of bilateral superior bladder arteries with excellent immediate results.The technique is safe and effective in the short term.The longterm effectiveness requires further investigation. 展开更多
关键词 urinary bladder neoplasms HEMATURIA Therapeutic embolisation
下载PDF
Unusual presentation of bladder neuroblastoma in a child: A case report
15
作者 Jia-Bin Cai Jin-Hu Wang +6 位作者 Min He Fa-Liang Wang Jie-Ni Xiong Jun-Qing Mao Min-Ju Li Kun Zhu Jia-Wei Liang 《World Journal of Clinical Cases》 SCIE 2020年第1期194-199,共6页
BACKGROUND Neuroblastoma is an extracranial malignant tumor in children that is most often located in the adrenal gland and sympathetic ganglion.Here,we present a rare case of neuroblastoma originating from the urinar... BACKGROUND Neuroblastoma is an extracranial malignant tumor in children that is most often located in the adrenal gland and sympathetic ganglion.Here,we present a rare case of neuroblastoma originating from the urinary bladder.CASE SUMMARY A 3-year-old girl presented with lower abdominal pain with micturition.Ultrasound revealed a lower abdominal mass.Abdominal computed tomography scan displayed a solitary mass at the top of the urinary bladder.Blood levels of neuron-specific enolase and lactate dehydrogenase were elevated.We treated the child with partial cystectomy and six courses of chemotherapy,and the outcome at 4-year follow-up was unremarkable.CONCLUSION Neuroblastoma should be considered when tumors are located in the urinary bladder,especially in the dome;although this presentation is rare,the prognosis is very good. 展开更多
关键词 NEUROBLASTOMA urinary bladder Pelvic neoplasms PROGNOSIS CHILD Case report
下载PDF
Successful treatment of solitary bladder plasmacytoma:A case report
16
作者 Jia-Dong Cao Peng-Hui Lin +1 位作者 Dan-Feng Cai Jia-Hua Liang 《World Journal of Clinical Cases》 SCIE 2021年第25期7453-7458,共6页
BACKGROUND Plasmacytoma is a rare neoplastic disorder that arises from B-lymphocytes.Solitary bladder plasmacytoma,a type of solitary extramedullary plasmacytoma,is even rarer.Treatments for solitary extramedullary pl... BACKGROUND Plasmacytoma is a rare neoplastic disorder that arises from B-lymphocytes.Solitary bladder plasmacytoma,a type of solitary extramedullary plasmacytoma,is even rarer.Treatments for solitary extramedullary plasmacytoma include surgery,chemotherapy,and radiation.However,there are no clinical trials or guidelines specifying which treatment might represent the gold standard.CASE SUMMARY We herein report a case of a 51-year-old woman with solitary bladder plasmacytoma(SBP).There remains no consensus regarding the optimal treatment for SBP.However,we successfully treated her with transurethral resection of bladder tumor followed by postoperative radiotherapy(50 Gy/25 F).The patient remained free of tumor recurrence at a 7-mo follow-up.CONCLUSION Radiation is the potential main treatment for SBP.However,surgery is also necessary. 展开更多
关键词 Bone marrow Local neoplasm recurrence Multiple myeloma M-proteins urinary bladder neoplasms Case report
下载PDF
Renal cell carcionoma with synchronous metastases to the bladder and lung
17
作者 Won Seok Jang In Sang Hwang +3 位作者 Eu Chang Hwang Seung Il Jung Dong Deuk Kwon Chan Choi 《Case Reports in Clinical Medicine》 2013年第2期97-99,共3页
Renal cell carcinoma can metastasize to virtually any organ, yet synchronous metastasis to the bladder is extremely rare. A 77-year-old woman presented with gross hematuria. Abdominal and chest computed tomography sho... Renal cell carcinoma can metastasize to virtually any organ, yet synchronous metastasis to the bladder is extremely rare. A 77-year-old woman presented with gross hematuria. Abdominal and chest computed tomography showed a bilateral renal masses, bladder dome mass, and multiple lung metastasis. Transurethral resection of the bladder tumor and sonography guided renal biopsy were performed. Both pathology diagnoses were clear cell renal cell carcinoma. Targeted therapy using pazopanib was administered to the patient without surgical resection of primary tumors and metastatic lung lesions. Herein, we report the synchronous metastasis of renal cell carcinoma to the bladder and lung. 展开更多
关键词 Carcinoma RENAL Cell urinary bladder LUNG neoplasm Metastasis
下载PDF
LINC00839靶向调控miR-124-3p对膀胱癌细胞生物学行为的影响 被引量:1
18
作者 吴潇芸 吴林秀 +4 位作者 张丽娣 蓝一笔 张明津 易楚繁 付伟金 《天津医药》 CAS 北大核心 2023年第5期464-468,共5页
目的探讨LINC00839靶向调控miR-124-3p对膀胱癌细胞生物学行为的影响。方法实时荧光定量PCR(qPCR)检测膀胱癌和癌旁正常组织、膀胱癌细胞株(T24、5637、EJ)中LINC00839表达及抑制LINC00839后对miR-124-3p表达的影响。构建3条小干扰RNA-L... 目的探讨LINC00839靶向调控miR-124-3p对膀胱癌细胞生物学行为的影响。方法实时荧光定量PCR(qPCR)检测膀胱癌和癌旁正常组织、膀胱癌细胞株(T24、5637、EJ)中LINC00839表达及抑制LINC00839后对miR-124-3p表达的影响。构建3条小干扰RNA-LINC00839(si-LINC00839-1组、si-LINC00839-2组和siLINC00839-3组)序列转染膀胱癌细胞。沉默LINC00839表达后,CCK-8检测LINC00839对细胞增殖的影响;Transwell检测LINC00839对细胞侵袭的影响;流式细胞术检测LINC00839对细胞凋亡的影响;双荧光素酶实验检测LINC00839与miR-124-3p的相互作用;免疫蛋白印迹法检测抑制LINC00839后对内皮素受体B(EDNRB)蛋白表达的影响。结果qPCR检测结果显示,与癌旁正常组织比较,膀胱癌组织中LINC00839表达增高(P<0.05);LINC00839在膀胱癌细胞5637表达最高。3条siRNA序列中,si-LINC00839-2抑制效率最高。与si-NC组相比,siLINC00839-2组细胞增殖率下降,侵袭数量减少,细胞凋亡率增加(P<0.05)。双荧光素酶报告检测结果显示,LINC00839与miR-124-3p之间存在互补结合位点。与si-NC组相比,si-LINC00839-2组可上调miR-124-3p表达,抑制EDNRB蛋白表达(P<0.05)。结论LINC00839可靶向调节miR-124-3p调控膀胱癌细胞增殖、侵袭和凋亡等生物学行为。 展开更多
关键词 膀胱肿瘤 细胞增殖 细胞凋亡 LINC00839 miR-124-3p
下载PDF
MRI平扫方案膀胱影像报告和数据系统对膀胱癌肌层浸润的诊断价值 被引量:1
19
作者 王玮 王鹤 +4 位作者 吴静云 李玮 曹新鸣 薛珂 邱建星 《中国医学影像学杂志》 CSCD 北大核心 2023年第5期517-521,528,共6页
目的 探究MRI平扫方案膀胱影像报告和数据系统(VI-RADS)评分对膀胱癌肌层浸润的诊断效能,探究定量参数肿瘤接触径线(TCL)对平扫VI-RADS评分的补充诊断价值。资料与方法 回顾性收集2020年10月—2021年8月于北京大学第一医院行膀胱多参数... 目的 探究MRI平扫方案膀胱影像报告和数据系统(VI-RADS)评分对膀胱癌肌层浸润的诊断效能,探究定量参数肿瘤接触径线(TCL)对平扫VI-RADS评分的补充诊断价值。资料与方法 回顾性收集2020年10月—2021年8月于北京大学第一医院行膀胱多参数MRI增强检查患者60例,以术后病理结果为诊断标准。测量肿瘤基底部与膀胱壁的最大TCL,在两组磁共振图像((1)平扫组:T2WI+扩散加权成像(DWI);(2)增强组:T2WI+DWI+DCE)上对膀胱癌进行VI-RADS评分,通过受试者工作特征曲线下面积(AUC)评价其诊断效能。结果 60例患者中,39例行经尿道电切手术,21例行根治性膀胱全切,最终37例(61.7%)诊断为非肌层浸润膀胱癌,23例(38.3%)诊断为肌层浸润膀胱癌。平扫组与增强组VI-RADS评分AUC比较,差异无统计学意义(0.948比0.954,P>0.05)。肌层浸润膀胱癌的TCL值[2.90(2.10,4.90)cm]大于非肌层浸润膀胱癌[1.40(0.85,2.00)cm](Z=4.171,P<0.001),其诊断肌层浸润膀胱癌的AUC为0.822。TCL联合平扫VI-RADS评分诊断肌层浸润膀胱癌AUC为0.953,较单独使用平扫VI-RADS评分略提升。结论 MRI平扫方案膀胱VI-RADS评分具有较高的肌层浸润诊断能力,联合定量参数TCL值可进一步提高其诊断效能。 展开更多
关键词 膀胱肿瘤 磁共振成像 数据系统 病理学 外科
下载PDF
表现不典型前列腺癌误诊原因探讨 被引量:2
20
作者 李岩 赵建华 +2 位作者 王雅楠 张亮 田翠莉 《临床误诊误治》 CAS 2023年第2期41-45,共5页
目的探讨前列腺癌的不典型临床特点及影像学表现,分析发生误诊的原因及防范误诊措施。方法对2019年6月-2020年12月收治病初曾误诊的前列腺癌8例临床资料进行回顾性分析。结果本组均为男性,年龄51~68岁,有吸烟史5例,平素饮酒4例。以尿频... 目的探讨前列腺癌的不典型临床特点及影像学表现,分析发生误诊的原因及防范误诊措施。方法对2019年6月-2020年12月收治病初曾误诊的前列腺癌8例临床资料进行回顾性分析。结果本组均为男性,年龄51~68岁,有吸烟史5例,平素饮酒4例。以尿频、尿急、排尿不畅困难及腰骶髋部疼痛为主要表现就诊,其中肉眼血尿1例,腰背部疼痛2例。2例行X线检查示腰4椎体退行性变;8例直肠指诊或直肠超声检查示前列腺均有不同程度增生,大小29.7~65.5 ml。误诊为膀胱癌1例、前列腺增生4例、腰椎间盘突出症2例、骨质疏松症1例。经术后病理或前列腺穿刺活检确诊为前列腺癌累及膀胱1例、A期前列腺癌4例、前列腺癌骨转移3例。8例确诊后,予手术、内分泌、放疗等综合治疗,术后随访至今均存活,预后尚可。结论前列腺癌发病较隐匿,进展缓慢,早期临床及影像学表现不典型,较易漏误诊。加强对前列腺癌的了解,提高警惕性,重视血前列腺特异性抗原筛查及直肠指诊,合理选择特异性影像学检查项目,必要时行前列腺穿刺活检,并增加穿刺点和穿刺次数以提高穿刺活检阳性检出率,可以减少前列腺癌误诊的发生。 展开更多
关键词 前列腺肿瘤 误诊 前列腺增生 膀胱肿瘤 腰椎间盘突出症 骨质疏松症 穿刺活检
下载PDF
上一页 1 2 67 下一页 到第
使用帮助 返回顶部